Navigation Links
Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011
Date:5/17/2011

SAN DIEGO, May 17, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it received the CLARUS Award presented by MDB Capital Group at the second annual Bright Lights Conference in New York City on May 10th.  The Bright Lights Conference is the only conference with an exclusive focus on publicly-traded companies possessing disruptive and market changing IP, providing institutional investors with a venue to discover the largely unrecognized value of embedded IP.

"Verenium was the top company in its industry with the highest Tech Score and number of patent grants, and we are honored to recognize their achievements in driving IP as an asset class and the impact they are making on innovation in America," commented Christopher A. Marlett, CEO of MDB Capital Group.

Verenium's technology was selected from MDB's 2011 group of "Best and Brightest" small-cap companies, a group that is advancing some of today's most innovative and market-leading intellectual property (IP) and advanced as one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform. Verenium was recognized for its innovation leadership and achieving the highest Tech Score and number of patent grants.

"We are honored to have received the CLARUS award, further affirmation of the strength of Verenium's intellectual property and core technology platform," said James Levine, President and Chief Executive Officer at Verenium.  "Verenium's proven proprietary technology enables the rapid discovery and evolution of uniquely tailored enzymes optimized for performance in challengi
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Verenium to Present at Upcoming Conferences
2. Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
3. Verenium to Present at MDB Capital Groups Bright Lights Conference
4. Verenium Announces Debt Repurchase
5. Worlds Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Vereniums Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval
6. Verenium Corporation to Announce Fourth Quarter and Year-End 2010 Financial Results
7. Verenium to Present at Jefferies 11th Global Clean Technology Conference
8. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
9. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
10. Verenium Reports Financial Results for the Third Quarter 2010
11. Verenium to Present at Jefferies 10th Global Clean Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Look inside the new Preferred Solutions® ... lab, from fluid handling to instruments to supplies. Many ... you order. , Preferred Solutions features a full ... L/S® model for precise flow control and dispensing to ...
(Date:1/15/2014)... England , January 15, 2014 A ... win races on the Formula 1 track could help to ... McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based in ... by healthcare provider Simplyhealth. Telemetry technology, which is ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... session for Thursday, January 23, 2014 at 2pm EST ... Actionable Knowledge.” The topic focuses on how technology can ... mission critical decisions for government agencies. The online webinar ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... 25 Tengion Inc., a clinical stage regenerative medicine company focused ... Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present ... 2, 2008 at 9:50 a.m. EST at The Palace Hotel in ... About Tengion , , ...
... RICHMOND, Va., Nov. 25 Insmed Inc. (Nasdaq: ... today that Dr. Geoffrey Allan, President and CEO of Insmed, ... View Conference on December 3, 2008, in New York. , ... conference is to better educate the investment community on the ...
... (Nasdaq: IDEV ) today announced its consolidated results,of ... September,30, 2008. The Company will host a conference call ... below). , The Company ... 18% from fiscal 2007 revenues of $66.1 million. For ...
Cached Biology Technology:Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11
(Date:7/9/2014)... a cell divides, it must first make a copy of ... cells that occurs billions of times a day in the ... molecular tools that cells use to replicate DNAthe enzymes that ... have a clear picture of how the process works. , ... system to decipher what goes on at the "replication fork"the ...
(Date:7/8/2014)... the world,s coral reefs and the animals that depend ... one tiny symbiotic sea creature to get fatand to ... with. , In the first study of its kind, ... reef-forming animals that live symbiotically with algaeare better able ... "bleaching," when they keep large energy reservesmostly as fatsocked ...
(Date:7/8/2014)... an increased risk of severe perineal tearing during childbirth in ... suggests a new study published today (9 July) in ... , This study, investigates among women who have had a ... in subsequent pregnancies and the recurrence of severe perineal tears. ... and in some women the tear may be more extensive. ...
Breaking Biology News(10 mins):Rockefeller scientists first to reconstitute the DNA 'replication fork' 2Rockefeller scientists first to reconstitute the DNA 'replication fork' 3Rockefeller scientists first to reconstitute the DNA 'replication fork' 4For corals adapting to climate change, it's survival of the fattest -- and most flexible 2For corals adapting to climate change, it's survival of the fattest -- and most flexible 3For corals adapting to climate change, it's survival of the fattest -- and most flexible 4Mode of delivery following a perineal tear and recurrence rate in subsequent pregnancies 2
... of North Carolina Hospitals arrived in February sporting three ... in helping to repair heart valves, remove cancerous prostates, ... for morbid obesity. , The new arrival is a ... Intuitive Surgical. UNC currently is the only gynecological oncology ...
... of North Carolina Hospitals arrived in February sporting three ... in helping to repair heart valves, remove cancerous prostates, ... for morbid obesity. , The new arrival is a ... Intuitive Surgical. UNC currently is the only gynecological oncology ...
... disease and climate change may have applications for ... American Phytopathological Society (APS). , According to David ... plants possess unique mechanisms of resistance to microbial ... able to apply the novel mechanisms found in ...
Cached Biology News:FDA: 'Highly Unlikely' Green Tea Lowers Cancer Risk 2FDA: 'Highly Unlikely' Green Tea Lowers Cancer Risk 3Screen all at risk for HIV, plus pregnant women 2Screen all at risk for HIV, plus pregnant women 3
... numbers of samples may be carried out using ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...
Heavy-duty rim. Especially recommended as a titration flask. Corning5100. capacity 250 mL Special grade: student grade...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (F1676) or contact customer s...
Mouse monoclonal [YPF19] to Yersinia pestis F1 antigen ( Abpromise for all tested applications)....
Biology Products: